NDC properties for "lidocaine 7 % / tetracaine 7 % Topical Cream" (RxCUI 687443)
About this data
The tables show NDC propoerties for lidocaine 7 % / tetracaine 7 % Topical Cream with the RxCUI 687443
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for lidocaine 7 % / tetracaine 7 % Topical Cream (RxCUI 687443)
| MMSL_CODE | BD28131 |
|---|---|
| MMSL_CODE | CD28131 |
| RxCUI | 687443 |
| SNOMEDCT | 425136005 |
| SPL_SET_ID | db56db69-969e-4d35-93ce-f1208a965631 |
| VUID | 4032124 |
| Prescribable Synonym | lidocaine 7 % / tetracaine 7 % Topical Cream |
| RXNAV_STR | lidocaine 70 MG/ML / tetracaine 70 MG/ML Topical Cream |
| RxNorm Name | lidocaine 70 MG/ML / tetracaine 70 MG/ML Topical Cream |
| RxNorm Synonym | lidocaine 7 % / tetracaine 7 % Topical Cream |
| Related queries | Interactions (for RxCUI 687443) |
NDC Properties
NDC Item 69420307701
| NDC 9 | 69420-3077 |
|---|---|
| NDC 10 | 69420-3077-1 |
| NDC Item | 69420307701 |
| Packaging | 30 g in 1 TUBE, WITH APPLICATOR (69420-3077-1) |
| FDA SPL set id | 510238 |
| Labeler | SA3, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2020-03-13 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 69420-3077 |
NDC Item 71800063104
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-04 |
| NDC Item | 71800063104 |
| Packaging | 4 TUBE in 1 CARTON (71800-631-04) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 71800063108
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-08 |
| NDC Item | 71800063108 |
| Packaging | 8 TUBE in 1 CARTON (71800-631-08) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 71800063115
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-15 |
| NDC Item | 71800063115 |
| Packaging | 1 TUBE in 1 CARTON (71800-631-15) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 69420307701
| NDC 9 | 69420-3077 |
|---|---|
| NDC 10 | 69420-3077-1 |
| NDC Item | 69420307701 |
| Packaging | 30 g in 1 TUBE, WITH APPLICATOR (69420-3077-1) |
| FDA SPL set id | 510238 |
| Labeler | SA3, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2020-03-13 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 69420-3077 |
NDC Item 71800063104
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-04 |
| NDC Item | 71800063104 |
| Packaging | 4 TUBE in 1 CARTON (71800-631-04) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 71800063108
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-08 |
| NDC Item | 71800063108 |
| Packaging | 8 TUBE in 1 CARTON (71800-631-08) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 71800063115
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-15 |
| NDC Item | 71800063115 |
| Packaging | 1 TUBE in 1 CARTON (71800-631-15) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 69420307701
| NDC 9 | 69420-3077 |
|---|---|
| NDC 10 | 69420-3077-1 |
| NDC Item | 69420307701 |
| Packaging | 30 g in 1 TUBE, WITH APPLICATOR (69420-3077-1) |
| FDA SPL set id | 510238 |
| Labeler | SA3, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2020-03-13 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 69420-3077 |
NDC Item 71800063104
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-04 |
| NDC Item | 71800063104 |
| Packaging | 4 TUBE in 1 CARTON (71800-631-04) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 71800063108
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-08 |
| NDC Item | 71800063108 |
| Packaging | 8 TUBE in 1 CARTON (71800-631-08) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 71800063115
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-15 |
| NDC Item | 71800063115 |
| Packaging | 1 TUBE in 1 CARTON (71800-631-15) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 69420307701
| NDC 9 | 69420-3077 |
|---|---|
| NDC 10 | 69420-3077-1 |
| NDC Item | 69420307701 |
| Packaging | 30 g in 1 TUBE, WITH APPLICATOR (69420-3077-1) |
| FDA SPL set id | 510238 |
| Labeler | SA3, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2020-03-13 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 69420-3077 |
NDC Item 71800063104
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-04 |
| NDC Item | 71800063104 |
| Packaging | 4 TUBE in 1 CARTON (71800-631-04) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 71800063108
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-08 |
| NDC Item | 71800063108 |
| Packaging | 8 TUBE in 1 CARTON (71800-631-08) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |
NDC Item 71800063115
| NDC 9 | 71800-631 |
|---|---|
| NDC 10 | 71800-631-15 |
| NDC Item | 71800063115 |
| Packaging | 1 TUBE in 1 CARTON (71800-631-15) / 30 g in 1 TUBE |
| FDA SPL set id | 591823 |
| Labeler | Innovida Pharmaceutique Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2017-05-03 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021717 |
| Related queries | Properties for NDC 9 71800-631 |